ndfresearch.com/blog

Novogen (ASX: NRT) ​- Picking up where Genentech left off

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

SUDA ​- Faster, safer delivery for ex-blockbusters​

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Cynata ​- The Swiss Army Knife of cellular remedies

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Resonance Health - MRI for the masses

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Dimerix's Phase 2 success for DMX-200 - an important potential new treatment option for kidney disease

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

ResApp Health - First major clinical study of ResAppDx reports important data

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Phylogica - In good company

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Optiscan Imaging - The phoenix rises from the ashes

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Anatara Lifesciences ​- A good gut feeling

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Alcidion - Making hospitals smarter with Clinical Decision Support

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research